Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1994 Aug;94(2):506–515. doi: 10.1172/JCI117362

Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. Identification of thirteen novel mutations in the thyroid hormone receptor beta gene.

M Adams 1, C Matthews 1, T N Collingwood 1, Y Tone 1, P Beck-Peccoz 1, K K Chatterjee 1
PMCID: PMC296123  PMID: 8040303

Abstract

Resistance to thyroid hormone (RTH), with elevated serum free thyroid hormones and nonsuppressed thyrotropin levels, is either relatively asymptomatic, suggesting a generalized disorder (GRTH) or associated with thyrotoxic features, indicating possible selective pituitary resistance (PRTH). 20 GRTH and 9 PRTH cases, sporadic or dominantly inherited, were analyzed. Affected individuals were heterozygous for single nucleotide substitutions in the thyroid hormone receptor beta gene, except for a single case of a seven nucleotide insertion. With one exception, the corresponding 13 novel and 7 known codon changes localized to and extended the boundaries of two mutation clusters in the hormone-binding domain of the receptor. 15 kindreds shared 6 different mutations, and haplotype analyses of the mutant allele showed that they occurred independently. The majority (14 out of 19) of the recurrent but a minority (1 out of 10) of unique mutations were transitions of CpG dinucleotides. Mutant receptor binding to ligand was moderately or severely impaired and did not correlate with the magnitude of thyroid dysfunction. There was no association between clinical features and the nature or location of a receptor mutation. These observations suggest that GRTH and PRTH are phenotypic variants of the same genetic disorder, whose clinical expression may be modulated by other non-mutation-related factors.

Full text

PDF
506

Images in this article

510Image
on p.510
511Image
on p.511

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams M., Nagaya T., Tone Y., Jameson J. L., Chatterjee V. K. Functional properties of a novel mutant thyroid hormone receptor in a family with generalized thyroid hormone resistance syndrome. Clin Endocrinol (Oxf) 1992 Mar;36(3):281–289. doi: 10.1111/j.1365-2265.1992.tb01444.x. [DOI] [PubMed] [Google Scholar]
  2. Beck-Peccoz P., Roncoroni R., Mariotti S., Medri G., Marcocci C., Brabant G., Forloni F., Pinchera A., Faglia G. Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): evidence against selective pituitary thyroid hormone resistance in nonneoplastic IST. J Clin Endocrinol Metab. 1990 Jul;71(1):19–25. doi: 10.1210/jcem-71-1-19. [DOI] [PubMed] [Google Scholar]
  3. Behr M., Loos U. A point mutation (Ala229 to Thr) in the hinge domain of the c-erbA beta thyroid hormone receptor gene in a family with generalized thyroid hormone resistance. Mol Endocrinol. 1992 Jul;6(7):1119–1126. doi: 10.1210/mend.6.7.1324420. [DOI] [PubMed] [Google Scholar]
  4. Boothroyd C. V., Teh B. T., Hayward N. K., Hickman P. E., Ward G. J., Cameron D. P. Single base mutation in the hormone binding domain of the thyroid hormone receptor beta gene in generalised thyroid hormone resistance demonstrated by single stranded conformation polymorphism analysis. Biochem Biophys Res Commun. 1991 Jul 31;178(2):606–612. doi: 10.1016/0006-291x(91)90151-v. [DOI] [PubMed] [Google Scholar]
  5. Burman K. D., Djuh Y. Y., Nicholson D., Rhooms P., Wartofsky L., Fein H. G., Usala S. J., Hao E. H., Bradley W. E., Berard J. Generalized thyroid hormone resistance: identification of an arginine to cystine mutation in codon 315 of the c-erb A beta thyroid hormone receptor. J Endocrinol Invest. 1992 Sep;15(8):573–579. doi: 10.1007/BF03344927. [DOI] [PubMed] [Google Scholar]
  6. Chatterjee V. K., Nagaya T., Madison L. D., Datta S., Rentoumis A., Jameson J. L. Thyroid hormone resistance syndrome. Inhibition of normal receptor function by mutant thyroid hormone receptors. J Clin Invest. 1991 Jun;87(6):1977–1984. doi: 10.1172/JCI115225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cooper D. N., Krawczak M. The mutational spectrum of single base-pair substitutions causing human genetic disease: patterns and predictions. Hum Genet. 1990 Jun;85(1):55–74. doi: 10.1007/BF00276326. [DOI] [PubMed] [Google Scholar]
  8. Cooper D. N., Youssoufian H. The CpG dinucleotide and human genetic disease. Hum Genet. 1988 Feb;78(2):151–155. doi: 10.1007/BF00278187. [DOI] [PubMed] [Google Scholar]
  9. Crinò A., Borrelli P., Salvatori R., Cortelazzi D., Roncoroni R., Beck-Peccoz P. Anti-iodothyronine autoantibodies in a girl with hyperthyroidism due to pituitary resistance to thyroid hormones. J Endocrinol Invest. 1992 Feb;15(2):113–120. doi: 10.1007/BF03348675. [DOI] [PubMed] [Google Scholar]
  10. Cugini C. D., Jr, Leidy J. W., Jr, Chertow B. S., Bérard J., Bradley W. E., Menke J. B., Hao E. H., Usala S. J. An arginine to histidine mutation in codon 315 of the c-erbA beta thyroid hormone receptor in a kindred with generalized resistance to thyroid hormones results in a receptor with significant 3,5,3'-triiodothyronine binding activity. J Clin Endocrinol Metab. 1992 May;74(5):1164–1170. doi: 10.1210/jcem.74.5.1314846. [DOI] [PubMed] [Google Scholar]
  11. Falcone M., Miyamoto T., Fierro-Renoy F., Macchia E., DeGroot L. J. Antipeptide polyclonal antibodies specifically recognize each human thyroid hormone receptor isoform. Endocrinology. 1992 Nov;131(5):2419–2429. doi: 10.1210/endo.131.5.1425440. [DOI] [PubMed] [Google Scholar]
  12. Forman B. M., Yang C. R., Au M., Casanova J., Ghysdael J., Samuels H. H. A domain containing leucine-zipper-like motifs mediate novel in vivo interactions between the thyroid hormone and retinoic acid receptors. Mol Endocrinol. 1989 Oct;3(10):1610–1626. doi: 10.1210/mend-3-10-1610. [DOI] [PubMed] [Google Scholar]
  13. Ganly P. S., Jarad N., Rudd R. M., Rabbitts P. H. PCR-based RFLP analysis allows genotyping of the short arm of chromosome 3 in small biopsies from patients with lung cancer. Genomics. 1992 Feb;12(2):221–228. doi: 10.1016/0888-7543(92)90369-4. [DOI] [PubMed] [Google Scholar]
  14. Geffner M. E., Su F., Ross N. S., Hershman J. M., Van Dop C., Menke J. B., Hao E., Stanzak R. K., Eaton T., Samuels H. H. An arginine to histidine mutation in codon 311 of the C-erbA beta gene results in a mutant thyroid hormone receptor that does not mediate a dominant negative phenotype. J Clin Invest. 1993 Feb;91(2):538–546. doi: 10.1172/JCI116233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gershengorn M. C., Weintraub B. D. Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of "inappropriate secretion of TSH". J Clin Invest. 1975 Sep;56(3):633–642. doi: 10.1172/JCI108133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hayashi Y., Janssen O. E., Weiss R. E., Murata Y., Seo H., Refetoff S. The relative expression of mutant and normal thyroid hormone receptor genes in patients with generalized resistance to thyroid hormone determined by estimation of their specific messenger ribonucleic acid products. J Clin Endocrinol Metab. 1993 Jan;76(1):64–69. doi: 10.1210/jcem.76.1.8421105. [DOI] [PubMed] [Google Scholar]
  17. Hermus A., Ross H., van Liessum P., Naber A., Smals A., Kloppenborg P. Hyperthyroidism due to inappropriate secretion of thyroid-stimulating hormone: diagnosis and management. Neth J Med. 1991 Jun;38(5-6):193–198. [PubMed] [Google Scholar]
  18. Hughes M. R., Malloy P. J., Kieback D. G., Kesterson R. A., Pike J. W., Feldman D., O'Malley B. W. Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. Science. 1988 Dec 23;242(4886):1702–1705. doi: 10.1126/science.2849209. [DOI] [PubMed] [Google Scholar]
  19. Klann R. C., Torres B., Menke J. B., Holbrook C. T., Bercu B. B., Usala S. J. Competitive polymerase chain reaction quantitation of c-erbA beta 1, c-erbA alpha 1, and c-erbA alpha 2 messenger ribonucleic acid levels in normal, heterozygous, and homozygous fibroblasts of kindred S with thyroid hormone resistance. J Clin Endocrinol Metab. 1993 Oct;77(4):969–975. doi: 10.1210/jcem.77.4.8408473. [DOI] [PubMed] [Google Scholar]
  20. Kliewer S. A., Umesono K., Mangelsdorf D. J., Evans R. M. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature. 1992 Jan 30;355(6359):446–449. doi: 10.1038/355446a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lazar M. A. Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr Rev. 1993 Apr;14(2):184–193. doi: 10.1210/edrv-14-2-184. [DOI] [PubMed] [Google Scholar]
  22. Lindstedt G., Lundberg P. A., Sjögren B., Ernest I., Sundquist O. Thyroid hormone resistance in a 35-year old man with recurrent goitre. Scand J Clin Lab Invest. 1982 Nov;42(7):585–593. [PubMed] [Google Scholar]
  23. McPhaul M. J., Marcelli M., Zoppi S., Griffin J. E., Wilson J. D. Genetic basis of endocrine disease. 4. The spectrum of mutations in the androgen receptor gene that causes androgen resistance. J Clin Endocrinol Metab. 1993 Jan;76(1):17–23. doi: 10.1210/jcem.76.1.8421085. [DOI] [PubMed] [Google Scholar]
  24. Meier C. A., Dickstein B. M., Ashizawa K., McClaskey J. H., Muchmore P., Ransom S. C., Menke J. B., Hao E. H., Usala S. J., Bercu B. B. Variable transcriptional activity and ligand binding of mutant beta 1 3,5,3'-triiodothyronine receptors from four families with generalized resistance to thyroid hormone. Mol Endocrinol. 1992 Feb;6(2):248–258. doi: 10.1210/mend.6.2.1569968. [DOI] [PubMed] [Google Scholar]
  25. Meier C. A., Parkison C., Chen A., Ashizawa K., Meier-Heusler S. C., Muchmore P., Cheng S. Y., Weintraub B. D. Interaction of human beta 1 thyroid hormone receptor and its mutants with DNA and retinoid X receptor beta. T3 response element-dependent dominant negative potency. J Clin Invest. 1993 Oct;92(4):1986–1993. doi: 10.1172/JCI116793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Mixson A. J., Hauser P., Tennyson G., Renault J. C., Bodenner D. L., Weintraub B. D. Differential expression of mutant and normal beta T3 receptor alleles in kindreds with generalized resistance to thyroid hormone. J Clin Invest. 1993 May;91(5):2296–2300. doi: 10.1172/JCI116458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Mixson A. J., Parrilla R., Ransom S. C., Wiggs E. A., McClaskey J. H., Hauser P., Weintraub B. D. Correlations of language abnormalities with localization of mutations in the beta-thyroid hormone receptor in 13 kindreds with generalized resistance to thyroid hormone: identification of four new mutations. J Clin Endocrinol Metab. 1992 Oct;75(4):1039–1045. doi: 10.1210/jcem.75.4.1400869. [DOI] [PubMed] [Google Scholar]
  28. Mixson A. J., Renault J. C., Ransom S., Bodenner D. L., Weintraub B. D. Identification of a novel mutation in the gene encoding the beta-triiodothyronine receptor in a patient with apparent selective pituitary resistance to thyroid hormone. Clin Endocrinol (Oxf) 1993 Mar;38(3):227–234. doi: 10.1111/j.1365-2265.1993.tb00999.x. [DOI] [PubMed] [Google Scholar]
  29. Nagaya T., Eberhardt N. L., Jameson J. L. Thyroid hormone resistance syndrome: correlation of dominant negative activity and location of mutations. J Clin Endocrinol Metab. 1993 Oct;77(4):982–990. doi: 10.1210/jcem.77.4.8408475. [DOI] [PubMed] [Google Scholar]
  30. Nagaya T., Jameson J. L. Thyroid hormone receptor dimerization is required for dominant negative inhibition by mutations that cause thyroid hormone resistance. J Biol Chem. 1993 Jul 25;268(21):15766–15771. [PubMed] [Google Scholar]
  31. Nagaya T., Madison L. D., Jameson J. L. Thyroid hormone receptor mutants that cause resistance to thyroid hormone. Evidence for receptor competition for DNA sequences in target genes. J Biol Chem. 1992 Jun 25;267(18):13014–13019. [PubMed] [Google Scholar]
  32. O'Donnell A. L., Koenig R. J. Mutational analysis identifies a new functional domain of the thyroid hormone receptor. Mol Endocrinol. 1990 May;4(5):715–720. doi: 10.1210/mend-4-5-715. [DOI] [PubMed] [Google Scholar]
  33. Ono S., Schwartz I. D., Mueller O. T., Root A. W., Usala S. J., Bercu B. B. Homozygosity for a dominant negative thyroid hormone receptor gene responsible for generalized resistance to thyroid hormone. J Clin Endocrinol Metab. 1991 Nov;73(5):990–994. doi: 10.1210/jcem-73-5-990. [DOI] [PubMed] [Google Scholar]
  34. Parrilla R., Mixson A. J., McPherson J. A., McClaskey J. H., Weintraub B. D. Characterization of seven novel mutations of the c-erbA beta gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two "hot spot" regions of the ligand binding domain. J Clin Invest. 1991 Dec;88(6):2123–2130. doi: 10.1172/JCI115542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Persani L., Asteria C., Tonacchera M., Vitti P., Krishna V., Chatterjee K., Beck-Peccoz P. Evidence for the secretion of thyrotropin with enhanced bioactivity in syndromes of thyroid hormone resistance. J Clin Endocrinol Metab. 1994 May;78(5):1034–1039. doi: 10.1210/jcem.78.5.8175956. [DOI] [PubMed] [Google Scholar]
  36. Refetoff S., Weiss R. E., Usala S. J. The syndromes of resistance to thyroid hormone. Endocr Rev. 1993 Jun;14(3):348–399. doi: 10.1210/edrv-14-3-348. [DOI] [PubMed] [Google Scholar]
  37. Rodd C., Schwartz H. L., Strait K. A., Oppenheimer J. H. Ontogeny of hepatic nuclear triiodothyronine receptor isoforms in the rat. Endocrinology. 1992 Dec;131(6):2559–2564. doi: 10.1210/endo.131.6.1446599. [DOI] [PubMed] [Google Scholar]
  38. Saijo T., Ito M., Takeda E., Huq A. H., Naito E., Yokota I., Sone T., Pike J. W., Kuroda Y. A unique mutation in the vitamin D receptor gene in three Japanese patients with vitamin D-dependent rickets type II: utility of single-strand conformation polymorphism analysis for heterozygous carrier detection. Am J Hum Genet. 1991 Sep;49(3):668–673. [PMC free article] [PubMed] [Google Scholar]
  39. Sakurai A., Miyamoto T., Refetoff S., DeGroot L. J. Dominant negative transcriptional regulation by a mutant thyroid hormone receptor-beta in a family with generalized resistance to thyroid hormone. Mol Endocrinol. 1990 Dec;4(12):1988–1994. doi: 10.1210/mend-4-12-1988. [DOI] [PubMed] [Google Scholar]
  40. Sakurai A., Nakai A., DeGroot L. J. Structural analysis of human thyroid hormone receptor beta gene. Mol Cell Endocrinol. 1990 Jun 18;71(2):83–91. doi: 10.1016/0303-7207(90)90245-4. [DOI] [PubMed] [Google Scholar]
  41. Sakurai A., Takeda K., Ain K., Ceccarelli P., Nakai A., Seino S., Bell G. I., Refetoff S., DeGroot L. J. Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor beta. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8977–8981. doi: 10.1073/pnas.86.22.8977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Sasaki S., Nakamura H., Tagami T., Miyoshi Y., Nogimori T., Mitsuma T., Imura H. Pituitary resistance to thyroid hormone associated with a base mutation in the hormone-binding domain of the human 3,5,3'-triiodothyronine receptor-beta. J Clin Endocrinol Metab. 1993 May;76(5):1254–1258. doi: 10.1210/jcem.76.5.8496318. [DOI] [PubMed] [Google Scholar]
  43. Sasaki S., Nakamura H., Tagami T., Miyoshi Y., Tanaka K., Imura H. A point mutation of the T3 receptor beta 1 gene in a kindred of generalized resistance to thyroid hormone. Mol Cell Endocrinol. 1992 Apr;84(3):159–166. doi: 10.1016/0303-7207(92)90026-3. [DOI] [PubMed] [Google Scholar]
  44. Shuto Y., Wakabayashi I., Amuro N., Minami S., Okazaki T. A point mutation in the 3,5,3'-triiodothyronine-binding domain of thyroid hormone receptor-beta associated with a family with generalized resistance to thyroid hormone. J Clin Endocrinol Metab. 1992 Jul;75(1):213–217. doi: 10.1210/jcem.75.1.1619012. [DOI] [PubMed] [Google Scholar]
  45. Spanjaard R. A., Darling D. S., Chin W. W. Ligand-binding and heterodimerization activities of a conserved region in the ligand-binding domain of the thyroid hormone receptor. Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8587–8591. doi: 10.1073/pnas.88.19.8587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Takeda K., Balzano S., Sakurai A., DeGroot L. J., Refetoff S. Screening of nineteen unrelated families with generalized resistance to thyroid hormone for known point mutations in the thyroid hormone receptor beta gene and the detection of a new mutation. J Clin Invest. 1991 Feb;87(2):496–502. doi: 10.1172/JCI115023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Takeda K., Weiss R. E., Refetoff S. Rapid localization of mutations in the thyroid hormone receptor-beta gene by denaturing gradient gel electrophoresis in 18 families with thyroid hormone resistance. J Clin Endocrinol Metab. 1992 Apr;74(4):712–719. doi: 10.1210/jcem.74.4.1548332. [DOI] [PubMed] [Google Scholar]
  48. Usala S. J., Bale A. E., Gesundheit N., Weinberger C., Lash R. W., Wondisford F. E., McBride O. W., Weintraub B. D. Tight linkage between the syndrome of generalized thyroid hormone resistance and the human c-erbA beta gene. Mol Endocrinol. 1988 Dec;2(12):1217–1220. doi: 10.1210/mend-2-12-1217. [DOI] [PubMed] [Google Scholar]
  49. Usala S. J., Menke J. B., Watson T. L., Bérard W. E., Bradley C., Bale A. E., Lash R. W., Weintraub B. D. A new point mutation in the 3,5,3'-triiodothyronine-binding domain of the c-erbA beta thyroid hormone receptor is tightly linked to generalized thyroid hormone resistance. J Clin Endocrinol Metab. 1991 Jan;72(1):32–38. doi: 10.1210/jcem-72-1-32. [DOI] [PubMed] [Google Scholar]
  50. Usala S. J., Menke J. B., Watson T. L., Wondisford F. E., Weintraub B. D., Bérard J., Bradley W. E., Ono S., Mueller O. T., Bercu B. B. A homozygous deletion in the c-erbA beta thyroid hormone receptor gene in a patient with generalized thyroid hormone resistance: isolation and characterization of the mutant receptor. Mol Endocrinol. 1991 Mar;5(3):327–335. doi: 10.1210/mend-5-3-327. [DOI] [PubMed] [Google Scholar]
  51. Usala S. J., Tennyson G. E., Bale A. E., Lash R. W., Gesundheit N., Wondisford F. E., Accili D., Hauser P., Weintraub B. D. A base mutation of the C-erbA beta thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds. J Clin Invest. 1990 Jan;85(1):93–100. doi: 10.1172/JCI114438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Weiss R. E., Marcocci C., Bruno-Bossio G., Refetoff S. Multiple genetic factors in the heterogeneity of thyroid hormone resistance. J Clin Endocrinol Metab. 1993 Jan;76(1):257–259. doi: 10.1210/jcem.76.1.8421095. [DOI] [PubMed] [Google Scholar]
  53. Weiss R. E., Weinberg M., Refetoff S. Identical mutations in unrelated families with generalized resistance to thyroid hormone occur in cytosine-guanine-rich areas of the thyroid hormone receptor beta gene. Analysis of 15 families. J Clin Invest. 1993 Jun;91(6):2408–2415. doi: 10.1172/JCI116474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Williams G., Kraenzlin M., Sandler L., Burrin J., Law A., Bloom S., Joplin G. F. Hyperthyroidism due to non-tumoural inappropriate TSH secretion. Effect of a long-acting somatostatin analogue (SMS 201-995). Acta Endocrinol (Copenh) 1986 Sep;113(1):42–46. [PubMed] [Google Scholar]
  55. Yen P. M., Darling D. S., Carter R. L., Forgione M., Umeda P. K., Chin W. W. Triiodothyronine (T3) decreases binding to DNA by T3-receptor homodimers but not receptor-auxiliary protein heterodimers. J Biol Chem. 1992 Feb 25;267(6):3565–3568. [PubMed] [Google Scholar]
  56. Yen P. M., Sugawara A., Refetoff S., Chin W. W. New insights on the mechanism(s) of the dominant negative effect of mutant thyroid hormone receptor in generalized resistance to thyroid hormone. J Clin Invest. 1992 Nov;90(5):1825–1831. doi: 10.1172/JCI116058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Zavacki A. M., Harney J. W., Brent G. A., Larsen P. R. Dominant negative inhibition by mutant thyroid hormone receptors is thyroid hormone response element and receptor isoform specific. Mol Endocrinol. 1993 Oct;7(10):1319–1330. doi: 10.1210/mend.7.10.8264663. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES